Healthcare provider profile · identity verified

Jonathan M Rief, MD

Family Practice · EAU CLAIRE, WI · NPI 1750841201

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	183
Levothyroxine Sodium	Levothyroxine Sodium	287	82
Lisinopril	Lisinopril	283	110
Amlodipine Besylate	Amlodipine Besylate	267	113
Tamsulosin Hcl	Tamsulosin Hcl	202	89
Losartan Potassium	Losartan Potassium	183	71
Metformin Hcl	Metformin Hcl	173	63
Metoprolol Succinate	Metoprolol Succinate	164	67
Rosuvastatin Calcium	Rosuvastatin Calcium	159	63
Metformin Hcl Er	Metformin Hcl	146	54
Simvastatin	Simvastatin	146	64
Gabapentin	Gabapentin	129	45
Omeprazole	Omeprazole	129	53
Hydrochlorothiazide	Hydrochlorothiazide	109	42
Pantoprazole Sodium	Pantoprazole Sodium	104	39
Trazodone Hcl	Trazodone Hcl	94	34
Warfarin Sodium	Warfarin Sodium	92	31
Furosemide	Furosemide	82	35
Metoprolol Tartrate	Metoprolol Tartrate	82	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	31
Famotidine	Famotidine	80	28
Citalopram Hbr	Citalopram Hydrobromide	78	22
Alendronate Sodium	Alendronate Sodium	74	23
Albuterol Sulfate Hfa	Albuterol Sulfate	70	32
Carvedilol	Carvedilol	67	20
Escitalopram Oxalate	Escitalopram Oxalate	67	27
Allopurinol	Allopurinol	66	24
Sertraline Hcl	Sertraline Hcl	63	21
Clopidogrel	Clopidogrel Bisulfate	58	19
Glipizide Er	Glipizide	58	22
Meloxicam	Meloxicam	56	28
Finasteride	Finasteride	55	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	53	39
Ozempic	Semaglutide	52	suppressed
Ventolin Hfa	Albuterol Sulfate	50	14
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	19
Fluticasone Propionate	Fluticasone Propionate	45	16
Jardiance	Empagliflozin	45	12
Tramadol Hcl	Tramadol Hcl	45	15
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	suppressed
Prednisone	Prednisone	43	29
Oxybutynin Chloride Er	Oxybutynin Chloride	41	15
Xarelto	Rivaroxaban	41	14
Atenolol	Atenolol	40	14
Eliquis	Apixaban	37	12
Terbinafine Hcl	Terbinafine Hcl	37	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	30
Celecoxib	Celecoxib	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	13
Pravastatin Sodium	Pravastatin Sodium	34	12
Propranolol Hcl	Propranolol Hcl	34	12
Carbamazepine Er	Carbamazepine	32	suppressed
Potassium Chloride	Potassium Chloride	32	11
Azithromycin	Azithromycin	31	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	12
Bupropion Xl	Bupropion Hcl	29	suppressed
Glipizide	Glipizide	29	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	19
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	15
Hydroxyzine Hcl	Hydroxyzine Hcl	26	12
Montelukast Sodium	Montelukast Sodium	26	11
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Topiramate	Topiramate	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Clonazepam	Clonazepam	17	suppressed
Ketoconazole	Ketoconazole	17	11
Mounjaro	Tirzepatide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Naproxen	Naproxen	14	suppressed
Torsemide	Torsemide	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Dapsone	Dapsone	12	suppressed
Digoxin	Digoxin	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error